NYSE$BLCO

Bausch + Lomb Corp · Q4 2025 earnings

Q4 2025 earnings · · Before market open · Investor relations

Briefing

Bausch + Lomb reported Q4 2025, revenue of $1.41B, net loss of $58M.

For Q4 2025, Bausch + Lomb reported revenue of $1.41B, a net loss of $58M. Management discusses segment performance, capital allocation, and outlook in the earnings release.

  • Revenue $1.41B.
  • Net loss $58M.
  • Bausch + Lomb highlights liquidity, operations, and 2026 priorities.

Headline financials

Total Revenue

$1.41B

Previous: $1.28B+9.8%
EPS (adj)

$0.32

Previous: $0.25+28.0%
Adjusted EBITDA

$326M

No prior period
Net Income

-$58M

Previous: -$3M-1833.3%
Operating Income

$112M

Previous: $87M+28.7%

Revenue & EPS history

Bausch + Lomb · Revenue · Quarterly

$1.41B

Q4 2025+9.8%vs Q4 2024
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

Bausch + Lomb · $1.01B total across 3 segments · Q3 2023

  • Vision Care
    $648M+8.4%
  • Surgical
    $185M+7.6%
  • Pharmaceuticals
    $174M+1.2%

Forward guidance

The release discusses Bausch + Lomb's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.

Tailwinds

  • Bausch + Lomb cites operational execution and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.

Headwinds

  • GAAP profitability remained under pressure in Q4 2025.
  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2025

Historical avgQ4 2025

-1.0%

Avg return

Earnings day

-1.8%

Avg return

5 days after

-1.0%

Avg return

30 days after

43%

9 / 21 earnings

Positive

+18.7%

Q4 2023

Best reaction

-15.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.8%+2.9%-1.0%
Q4 2025+0.2%+1.5%-11.3%
Q3 2025+2.1%+0.3%+6.5%
Q1 2025-15.7%-17.1%-16.4%
Q4 2024-0.3%-3.3%-4.8%
Q3 2024-2.3%-4.3%-4.5%
Q2 2024-0.1%-8.7%-2.6%
Q1 2024-4.7%-0.7%+5.5%
Q4 2023+18.7%+15.7%+10.8%
Q3 2023+4.6%+2.9%-4.3%
Q2 2023-2.5%-3.4%-7.2%
Q1 2023+0.1%+4.6%+4.4%
Q4 2020+0.4%-3.7%-14.1%
Q4 2022+0.4%-3.7%-14.1%
Q3 2022-4.9%+5.6%+7.9%
Q3 2021-4.9%+5.6%+7.9%
Q2 2022+4.7%+6.3%+1.2%
Q2 2021+4.7%+6.3%+1.2%
Q1 2022-6.8%-14.6%+5.0%
Q4 2021-6.8%-14.6%+5.0%
Q1 2021-6.8%-14.6%+5.0%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro